Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $41.7500 (0.86%) ($41.7500 - $41.7500) on Wed. Oct. 5, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.33% (three month average) | RSI | 43 | Latest Price | $41.7500(0.86%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO advances 0.8% a day on average for past five trading days. | Weekly Trend | HALO declines -0.3% a week on average for past two weeks. | Market Behavior | Normal for large cap. Value stock sell-off for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) IBB(41%) IFRA(34%) IWM(34%) IWO(34%) IWN(33%) | Factors Impacting HALO price | HALO will decline at least -1.165% in a week (0% probabilities). VIXM(-11%) VXX(-7%) TBT(-5%) UUP(-4%) USO(3%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.165% (StdDev 2.33%) | Hourly BBV | 1.8 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $40.44(3.24%) | 10 Day Moving Average | $39.82(4.85%) | 20 Day Moving Average | $40.42(3.29%) | To recent high | -19.5% | To recent low | 8.4% | Market Cap | $5.706b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |